Meng, G., Rutz, M., Schiemann, M., Metzger, J., Grabiec, A., Schwandner, R., . . . Kirschning, C. J. (2004). Antagonistic antibody prevents toll-like receptor 2–driven lethal shock-like syndromes. American Society for Clinical Investigation.
Stile di citazione ChicagoMeng, Guangxun, et al. Antagonistic Antibody Prevents Toll-like Receptor 2–driven Lethal Shock-like Syndromes. American Society for Clinical Investigation, 2004.
Citazione MLAMeng, Guangxun, et al. Antagonistic Antibody Prevents Toll-like Receptor 2–driven Lethal Shock-like Syndromes. American Society for Clinical Investigation, 2004.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.